Review article · 2024 · Open access
T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies
Cancers, 16(8), 1580 · Published 20 April 2024 · DOI 10.3390/cancers16081580
In brief
“T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies” is a 2024 review article by Paweł Cech and 3 co-authors, published in Cancers. OpenAlex counts 45 citations as of 18 November 2026, which puts it in the top 7% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Cancers.
- Citations
- 45
- Most cited in
- 2026 (23)
- Field-weighted impact
- 1.60
- References
- 155
- Authors
- 4
Abstract
Recent advancements in cancer immunotherapy have made directing the cellular immune response onto cancer cells a promising strategy for the treatment of hematological malignancies. The introduction of monoclonal antibody-based (mAbs) targeted therapy has significantly improved the prognosis for hematological patients. Facing the issues of mAb-based therapies, a novel bispecific antibody (BsAb) format was developed. T-cell engagers (TCEs) are BsAbs, which simultaneously target tumor-associated antigens on tumor cells and CD3 molecules present on T-cells. This mechanism allows for the direct activation of T-cells and their anti-tumor features, ultimately resulting in the lysis of tumor cells. In 2014, the FDA approved blinatumomab, a TCE directed to CD3 and CD19 for treatment of acute lymphoblastic leukemia. Since then, numerous TCEs have been developed, allowing for treating different hematological malignancies such as acute myeloid leukemia, multiple myeloma, and non-Hodgkin lymphoma and Hodgkin lymphoma. As of November 2023, seven clinically approved TCE therapies are on the market. TCE-based therapies still have their limitations; however, improving the properties of TCEs, as well as combining TCE-based therapies with other forms of treatment, give hope to find the cures for currently terminal diseases. In this paper, we summarized the technical basis of the TCE technology, its application in hematology, and its current issues and prospects.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Cech, P., Skórka, K., Dziki, L., & Giannopoulos, K. (2024). T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies. Cancers, 16(8), 1580. https://doi.org/10.3390/cancers16081580
MLA 9
Cech, Paweł, et al. “T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies.” Cancers, vol. 16, no. 8, 2024, p. 1580. https://doi.org/10.3390/cancers16081580.
Chicago
Cech, Paweł, Katarzyna Skórka, Laura Dziki, and Krzysztof Giannopoulos. 2024. “T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies.” Cancers 16 (8): 1580. https://doi.org/10.3390/cancers16081580.
Harvard
Cech, P. et al. (2024) ‘T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies’, Cancers, 16(8), p. 1580. doi:10.3390/cancers16081580.
IEEE
P. Cech, K. Skórka, L. Dziki, and K. Giannopoulos, “T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies,” Cancers, vol. 16, no. 8, p. 1580, 2024, doi: 10.3390/cancers16081580.
BibTeX
@article{cech2024cell,
title = {{T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies}},
author = {Cech, Paweł and Skórka, Katarzyna and Dziki, Laura and Giannopoulos, Krzysztof},
journal = {Cancers},
year = {2024},
volume = {16},
number = {8},
pages = {1580},
doi = {10.3390/cancers16081580},
url = {https://doi.org/10.3390/cancers16081580}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 2 | |
| 2025 | 20 | |
| 2026 | 23 |
Its field-weighted citation impact is 1.60: it has been cited 1.60 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- T-cell engagers
- bispecific antibodies
- CD3
- CD19
- blinatumomab
- hematologic malignancies
- acute lymphoblastic leukemia
- acute myeloid leukemia
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Cech, P., Skórka, K., Dziki, L., & Giannopoulos, K. (2024). T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies. Cancers, 16(8), 1580. https://doi.org/10.3390/cancers16081580
How many times has this paper been cited?
45 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Cancers: sign in and open the PDF from this page.
Who wrote this paper?
Paweł Cech, Katarzyna Skórka, Laura Dziki, Krzysztof Giannopoulos.
What is the DOI of this paper?
10.3390/cancers16081580, permanently at https://doi.org/10.3390/cancers16081580. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.